Silexion Therapeutics Ltd. (SLXN) Financials

SLXN Assets vs Liabilities
DateAssetsLiabilities
June 30, 2026 4.2 million 4.2 million
March 31, 2026 4.6 million 4.3 million
Dec. 31, 2025 7.2 million 4.6 million
Sept. 30, 2025 11.6 million 4.6 million

SLXN Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
June 30, 2026 -2.9 million 197000
March 31, 2026 -3.6 million 345000
Dec. 31, 2025 -3.0 million 38000
Sept. 30, 2025 -2.8 million 38000

SLXN Net Income

No data available :(

SLXN Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
June 30, 2026 2.2 million - 425000
March 31, 2026 2.4 million 251000 436000
Dec. 31, 2025 6.0 million 286000 468000
Sept. 30, 2025 9.2 million 311000 485000

SLXN Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
June 30, 2026 687353
March 31, 2026 323037
Dec. 31, 2025 312665
Sept. 30, 2025 113265

SLXN Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
June 30, 2026 - 2.2 million 1.5 million -
March 31, 2026 - 1.4 million 1.4 million -
Dec. 31, 2025 2000 3.4 million 1.0 million -
Sept. 30, 2025 - 2.2 million 1.1 million -

SLXN Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
June 30, 2026 - 3000
March 31, 2026 - 2000
Dec. 31, 2025 - 3000
Sept. 30, 2025 - 4000

SLXN

Price: $0.38

52 week price:
0.37
90.45

Earnings Per Share: -58.82 USD

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 569286

Links: